Zhang R - Search Results

1

Identification of the ZAK-MKK4-JNK-TGFβ signaling pathway as a molecular target for novel synthetic iminoquinone anticancer compound BA-TPQ.

Chen D, Wang W, Qin JJ, Wang MH, Murugesan S, Nadkarni DH, Velu SE, Wang H, Zhang R. Chen D, et al. Among authors: zhang r. Curr Cancer Drug Targets. 2013 Jul;13(6):651-60. doi: 10.2174/15680096113139990040. Curr Cancer Drug Targets. 2013. PMID: 23607596 Free PMC article.

2

Antisense anti-MDM2 oligonucleotides as a novel approach to the treatment of glioblastoma multiforme.

Prasad G, Wang H, Agrawal S, Zhang R. Prasad G, et al. Among authors: zhang r. Anticancer Res. 2002 Jan-Feb;22(1A):107-16. Anticancer Res. 2002. PMID: 12017271

3

Antisense oligonucleotides targeting RI alpha subunit of protein kinase A. In vitro and in vivo anti-tumor activity and pharmacokinetics.

Zhang R, Wang H. Zhang R, et al. Methods Mol Med. 2003;75:637-54. Methods Mol Med. 2003. PMID: 12407769 No abstract available.

4

Experimental therapy of human prostate cancer by inhibiting MDM2 expression with novel mixed-backbone antisense oligonucleotides: in vitro and in vivo activities and mechanisms.

Wang H, Yu D, Agrawal S, Zhang R. Wang H, et al. Among authors: zhang r. Prostate. 2003 Feb 15;54(3):194-205. doi: 10.1002/pros.10187. Prostate. 2003. PMID: 12518324

5

Antisense oligonucleotide inhibitors of MDM2 oncogene expression.

Zhang R, Wang H. Zhang R, et al. Methods Mol Med. 2003;85:205-22. doi: 10.1385/1-59259-380-1:205. Methods Mol Med. 2003. PMID: 12710210 Review. No abstract available.

6

Chemosensitization and radiosensitization of human cancer by antisense anti-MDM2 oligonucleotides: in vitro and in vivo activities and mechanisms.

Wang H, Oliver P, Zhang Z, Agrawal S, Zhang R. Wang H, et al. Among authors: zhang r, zhang z. Ann N Y Acad Sci. 2003 Dec;1002:217-35. doi: 10.1196/annals.1281.025. Ann N Y Acad Sci. 2003. PMID: 14751837

7

Recent advances in experimental molecular therapeutics for malignant gliomas.

Prasad G, Wang H, Hill DL, Zhang R. Prasad G, et al. Among authors: zhang r. Curr Med Chem Anticancer Agents. 2004 Jul;4(4):347-61. doi: 10.2174/1568011043352911. Curr Med Chem Anticancer Agents. 2004. PMID: 15281907 Review.

8

Wnt/beta-catenin signaling pathway as a novel cancer drug target.

Luu HH, Zhang R, Haydon RC, Rayburn E, Kang Q, Si W, Park JK, Wang H, Peng Y, Jiang W, He TC. Luu HH, et al. Among authors: zhang r. Curr Cancer Drug Targets. 2004 Dec;4(8):653-71. doi: 10.2174/1568009043332709. Curr Cancer Drug Targets. 2004. PMID: 15578921 Review.

9

MDM2 and human malignancies: expression, clinical pathology, prognostic markers, and implications for chemotherapy.

Rayburn E, Zhang R, He J, Wang H. Rayburn E, et al. Among authors: zhang r. Curr Cancer Drug Targets. 2005 Feb;5(1):27-41. doi: 10.2174/1568009053332636. Curr Cancer Drug Targets. 2005. PMID: 15720187 Review.

10

Novel antisense anti-MDM2 mixed-backbone oligonucleotides: proof of principle, in vitro and in vivo activities, and mechanisms.

Zhang R, Wang H, Agrawal S. Zhang R, et al. Curr Cancer Drug Targets. 2005 Feb;5(1):43-9. doi: 10.2174/1568009053332663. Curr Cancer Drug Targets. 2005. PMID: 15720188 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36,645 results

Search Page

Filters